The social and economic burden of retinopathy of prematurity: screening, treatment, and health policy perspectives in a transnational narrative review - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing the Economic and Social Impact of Retinopathy of Prematurity: Insights from a Global Narrative Review on Screening, Treatment, and Health Policy

  • By

  • Maria Ester Canepa

  • Massimiliano Serafino

  • Pasquale Striano

  • Luca A. Ramenghi

  • August 26, 2026

Share

  • 1

    Retinopathy of prematurity (ROP) is a significant preventable cause of childhood blindness, particularly affecting premature infants.

  • 2

    The review analyzed 15 primary studies and 71 additional publications on the economic and social burden of ROP from 2003 to 2025.

  • 3

    AI-assisted telescreening and smartphone imaging are identified as cost-effective screening options for ROP in various healthcare settings.

  • 4

    Long-term societal costs from ROP-related blindness exceed the costs of timely screening and early intervention.

  • 5

    Integrated screening programs and digital innovations in countries like Argentina and India may reduce preventable ROP-related blindness.

Original Source(s)

Related Content